209 related articles for article (PubMed ID: 26306842)
1. Emerging Pharmacological Treatments to Prevent Abdominal Aortic Aneurysm Growth and Rupture.
Fraga-Silva RA; Trachet B; Stergiopulos N
Curr Pharm Des; 2015; 21(28):4000-6. PubMed ID: 26306842
[TBL] [Abstract][Full Text] [Related]
2. Emerging Pharmacological Treatments to Prevent Abdominal Aortic Aneurysm Growth and Rupture.
Fraga-Silva RA; Trachet B; Stergiopulos N
Curr Pharm Des; 2015 Aug; ():. PubMed ID: 26306835
[TBL] [Abstract][Full Text] [Related]
3. Reconsidering gender relative to risk of rupture in the contemporary management of abdominal aortic aneurysms.
Skibba AA; Evans JR; Hopkins SP; Yoon HR; Katras T; Kalbfleisch JH; Rush DS
J Vasc Surg; 2015 Dec; 62(6):1429-36. PubMed ID: 26409846
[TBL] [Abstract][Full Text] [Related]
4. Anatomic characteristics of ruptured abdominal aortic aneurysm on conventional CT scans: Implications for rupture risk.
Fillinger MF; Racusin J; Baker RK; Cronenwett JL; Teutelink A; Schermerhorn ML; Zwolak RM; Powell RJ; Walsh DB; Rzucidlo EM
J Vasc Surg; 2004 Jun; 39(6):1243-52. PubMed ID: 15192565
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways.
Zhang XJ; He C; Tian K; Li P; Su H; Wan JB
Vascul Pharmacol; 2015 Oct; 73():86-95. PubMed ID: 25912763
[TBL] [Abstract][Full Text] [Related]
6. Pathological Analysis of the Ruptured Vascular Wall of Hypoperfusion-induced Abdominal Aortic Aneurysm Animal Model.
Kugo H; Zaima N; Tanaka H; Hashimoto K; Miyamoto C; Sawaragi A; Urano T; Unno N; Moriyama T
J Oleo Sci; 2017 May; 66(5):499-506. PubMed ID: 28381776
[TBL] [Abstract][Full Text] [Related]
7. Optimal Time for Pharmacological Treatment of Abdominal Aortic Aneurysm.
Iida Y; Sawa S; Shimizu H
Curr Drug Targets; 2018; 19(11):1297-1301. PubMed ID: 29284387
[TBL] [Abstract][Full Text] [Related]
8. Screening aortic drug treatments through arterial compliance measurements.
Rentschler ME; Baxter BT
Curr Vasc Pharmacol; 2008 Oct; 6(4):250-7. PubMed ID: 18855713
[TBL] [Abstract][Full Text] [Related]
9. Diameter-related variations of geometrical, mechanical, and mass fraction data in the anterior portion of abdominal aortic aneurysms.
Tong J; Cohnert T; Holzapfel GA
Eur J Vasc Endovasc Surg; 2015 Mar; 49(3):262-70. PubMed ID: 25617258
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse.
Moran CS; Rush CM; Dougan T; Jose RJ; Biros E; Norman PE; Gera L; Golledge J
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):898-907. PubMed ID: 26966276
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological approaches to prevent abdominal aortic aneurysm enlargement and rupture.
Rentschler M; Baxter BT
Ann N Y Acad Sci; 2006 Nov; 1085():39-46. PubMed ID: 17182921
[TBL] [Abstract][Full Text] [Related]
12. Should the size threshold for elective abdominal aortic aneurysm repair be lowered in the endovascular era? No.
Avgerinos ED; Katsargyris A; Klonaris C; Papapetrou A; Moulakakis K; Liapis CD
Angiology; 2010 Oct; 61(7):620-3. PubMed ID: 20823074
[TBL] [Abstract][Full Text] [Related]
13. Ultraviolet B Exposure Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice by Expanding CD4
Hayashi T; Sasaki N; Yamashita T; Mizoguchi T; Emoto T; Amin HZ; Yodoi K; Matsumoto T; Kasahara K; Yoshida N; Tabata T; Kitano N; Fukunaga A; Nishigori C; Rikitake Y; Hirata KI
J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28860231
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological treatment of abdominal aortic aneurysm.
Miyake T; Morishita R
Cardiovasc Res; 2009 Aug; 83(3):436-43. PubMed ID: 19454489
[TBL] [Abstract][Full Text] [Related]
15. Adventitial adipogenic degeneration is an unidentified contributor to aortic wall weakening in the abdominal aortic aneurysm.
Doderer SA; Gäbel G; Kokje VBC; Northoff BH; Holdt LM; Hamming JF; Lindeman JHN
J Vasc Surg; 2018 Jun; 67(6):1891-1900.e4. PubMed ID: 28912007
[TBL] [Abstract][Full Text] [Related]
16. Should the size threshold for elective abdominal aortic aneurysm repair be lowered in the endovascular era? Yes.
Paraskevas KI; Mikhailidis DP; Andrikopoulos V; Bessias N; Bell SP
Angiology; 2010 Oct; 61(7):617-9. PubMed ID: 20823073
[TBL] [Abstract][Full Text] [Related]
17. Standardization of outcome measures in clinical trials of pharmacological treatment for abdominal aortic aneurysm.
Wang XL; Thompson MM; Dole WP; Dalman RL; Zalewski A
Expert Rev Cardiovasc Ther; 2012 Oct; 10(10):1251-60. PubMed ID: 23113642
[TBL] [Abstract][Full Text] [Related]
18. Current Theories and Clinical Trial Evidence for Limiting Human Abdominal Aortic Aneurysm Growth.
Yu J; Liu S; Huang J; Wang W
Curr Drug Targets; 2018; 19(11):1302-1308. PubMed ID: 29141546
[TBL] [Abstract][Full Text] [Related]
19. Asymptomatic abdominal aortic aneurysms show histological signs of progression: a quantitative histochemical analysis.
Eberlová L; Tonar Z; Witter K; Křížková V; Nedorost L; Korabečná M; Tolinger P; Kočová J; Boudová L; Třeška V; Houdek K; Moláček J; Vrzalová J; Pešta M; Topolčan O; Valenta J
Pathobiology; 2013; 80(1):11-23. PubMed ID: 22797551
[TBL] [Abstract][Full Text] [Related]
20. Aortic outflow occlusion predicts rupture of abdominal aortic aneurysm.
Crawford JD; Chivukula VK; Haller S; Vatankhah N; Bohannan CJ; Moneta GL; Rugonyi S; Azarbal AF
J Vasc Surg; 2016 Dec; 64(6):1623-1628. PubMed ID: 27374068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
